Pharma VC Funds

Grey Silo Ventures, founded in 2022, is the corporate venture arm of Italy's Cereal Docks Group. It focuses on investing in early to mid-stage foodtech and agritech startups, particularly those driving sustainability and innovation in plant-based ingredients. Their mission is to revolutionize the food industry by supporting technologies that reduce reliance on animal-based products. Grey Silo has a strong international outlook, with a portfolio featuring companies like Juicy Marbles (alternative meat) and MicroHarvest (sustainable protein). Their investments focus on B2B food innovations, aiming to develop functional ingredients that enhance sustainability and authenticity. The fund typically backs startups in seed to Series A stages and provides not only capital but also access to Cereal Docks’ vast network, helping companies scale. Led by a team of seasoned professionals, including Managing Partner Giacomo Fanin and advisory board members like Enrico Costanzo, they offer deep industry expertise and innovation support. Grey Silo primarily targets Europe but maintains a global perspective as they push forward their vision of transforming the future of food.

Greycroft is a prominent venture capital firm that invests from seed to growth stages, managing over $3 billion in capital. The firm has a strong track record, having made over 400 investments across 32 states in the U.S. and 17 countries globally. Notable companies in Greycroft’s portfolio include Venmo, Bumble, Bird, Scopely, The RealReal, and Icertis. Greycroft's investment focus spans several sectors including consumer internet, enterprise software, fintech, and healthcare. Their strategy emphasizes supporting companies from early stages through to commercialization and eventual exit. The firm typically invests between $500K and $50 million in high-growth startups. The firm's bicoastal presence in Los Angeles and New York provides unique access to technological advancements and emerging trends. Co-founders Dana Settle and Ian Sigalow lead the firm with a strong emphasis on identifying innovative applications of next-generation technologies. Greycroft's approach is highly collaborative, working closely with entrepreneurs to provide strategic guidance, operational support, and access to an extensive network of industry leaders and investors​.

Greylock Partners, established in 1965, is a renowned venture capital firm with a strong focus on early-stage investments in consumer and enterprise software. Based in Silicon Valley, the firm manages over $3.5 billion in committed capital and has a history of backing transformative companies. Some of Greylock's most notable investments include Facebook, LinkedIn, Airbnb, Figma, and Instagram, reflecting their ability to identify and support high-impact startups. These companies have grown into industry giants, showcasing Greylock's strategic insight and commitment to fostering innovation. Other significant investments in their portfolio are Roblox, Discord, and Workday, which further illustrate their influence across various tech sectors​​. Greylock typically partners with companies from the pre-seed, seed, or Series A stages, often being the first check-in. Their investment approach is characterized by a deep engagement with their portfolio companies, providing not only financial support but also strategic guidance and operational expertise. This hands-on involvement has been crucial in helping startups achieve scalability and success​ ​. The firm has been led by notable partners such as Reid Hoffman and David Sze, who have driven some of Greylock’s most successful investments. Greylock continues to be a pivotal player in the venture capital space, leveraging their extensive experience and network to support the next generation of leading tech companies​.

GRIDS Capital, founded in 2016 by Guy and Isabelle Perelmuter, is a venture capital firm based in São Paulo, Brazil. The firm specializes in deep tech investments, focusing on sectors such as artificial intelligence, robotics, life sciences, advanced materials, tech infrastructure, and energy. GRIDS Capital aims to support groundbreaking technological innovations that merge science and technology to build a better future. The firm typically invests in seed to series B stages, with investment sizes ranging from $100,000 to $5 million, and a sweet spot of $2.5 million. GRIDS Capital's portfolio includes notable companies like Nabla Bio, LimaCharlie, and Aifleet. They have made 51 investments and achieved nine exits, including successful exits from companies like Avail Medsystems and Recursion Pharmaceuticals. GRIDS Capital prides itself on leveraging the expertise of entrepreneurs, researchers, scientists, engineers, and academics to drive the development of new algorithms, models, systems, devices, and products. Their strategic focus on deep tech positions them as a key player in advancing technological innovations that address complex global challenges.

Grok Ventures, founded by Mike Cannon-Brookes in 2008, is a prominent venture capital firm headquartered in Surry Hills, Australia. The firm is dedicated to addressing global challenges, particularly focusing on climate tech and sustainable investments. Grok Ventures boasts a diverse portfolio of over 50 companies, with notable investments including Zoox, Sun Cable, and Vow. These companies span various sectors such as renewable energy, electric vehicles, and food technology. Grok Ventures emphasizes early to growth-stage investments, with typical funding rounds ranging from $1M to $10M. The firm is known for its strategic, long-term approach, often leading investment rounds and actively participating in the growth of its portfolio companies. Grok Ventures seeks out innovative solutions that have the potential to make a significant environmental impact, aligning with their mission to foster a sustainable future. The leadership team, comprising Jeremy Kwong-Law and Tan Kueh as CEOs, alongside other key members like Lucinda Hankin and Sudipta Ghosh, brings a wealth of experience in technology and investment. This expertise, coupled with a robust network, allows Grok Ventures to support startups not only financially but also through mentorship and strategic guidance. Grok Ventures is particularly interested in projects that demonstrate technological innovation and scalability in climate tech. Entrepreneurs looking to pitch to Grok Ventures should highlight their potential for significant environmental impact and align with the firm’s sustainability goals. The firm prefers direct submissions through their website, encouraging detailed pitch decks that outline the unique value propositions of the startups. Overall, Grok Ventures remains committed to leveraging technology to drive positive change, supporting visionary entrepreneurs who are paving the way for a greener, more sustainable world.

Ground Up Ventures, established in 2017, is an early-stage venture capital firm with a unique focus on pre-seed and seed-stage startups in the United States and Israel. With headquarters in Philadelphia and additional offices in New York and Tel Aviv, the firm has built a robust portfolio that includes companies like TULU, TermScout, Wardrobe, and Jones Software. Ground Up Ventures primarily invests in SaaS, fintech, and proptech sectors. Their investment strategy is centered around partnering with mission-oriented founding teams that are building enduring businesses. They are known for their hands-on approach, providing support in areas such as fundraising, hiring, marketing, and strategy, effectively acting as an extension of their portfolio companies' teams​. The team is led by founding partners Cory Moelis and David Stark, who are based in Philadelphia and New York, respectively. They are supported by a diverse team including Navot Volk in Tel Aviv, ensuring a broad geographic reach and deep industry connections. This setup allows Ground Up Ventures to leverage a vast network, benefiting their portfolio companies through strategic introductions and partnerships. Ground Up Ventures writes checks typically ranging from $500K to $2M, focusing on companies that demonstrate strong potential for growth and disruption within their industries. They have made significant investments in innovative startups like Flyp, Komodor, and Lenkie, showcasing their commitment to supporting transformative technology solutions​.

Grove Ventures, an early-stage venture capital firm based in Tel Aviv, Israel, specializes in deep tech investments, partnering with innovative Israeli entrepreneurs. Founded in 2016 by Dov Moran, the inventor of the USB flash drive, and Lotan Levkowitz, the firm focuses on sectors such as edge computing, cloud infrastructure, AI, semiconductors, and digital health. Notable investments include companies like Wiliot, RapidAPI, and ActiveFence, which reflect Grove's commitment to fostering groundbreaking technologies. Their investment strategy emphasizes early-stage funding (Pre-Seed, Seed, and Series A) and supports startups with resources for further funding, HR and management recruitment, marketing, and sales. The firm recently closed its third fund at $185 million, bringing their total assets under management to nearly half a billion dollars​. Key team members include Managing Partner Dov Moran, General Partner Renana Ashkenazi, and Partner Lotan Levkowitz, all based in Tel Aviv. Grove Ventures is known for its hands-on approach, working closely with founders to build robust companies poised to shape the future through technological innovation. Startups looking to partner with Grove Ventures should focus on demonstrating how their technology can drive significant market impact and align with Grove's vision of the "Deep Future".

GrowX Ventures, founded in 2008 and based in New Delhi, is a venture capital firm that focuses on early-stage investments in the B2B and deep tech sectors. The firm has a diverse portfolio, with significant investments in companies like Pixxel, Progcap, and RACEnergy. GrowX Ventures supports startups with innovative solutions in fields such as enterprise SaaS, fintech, healthcare, and aerospace. The firm has made 77 investments, including recent funding for Tappi, a company focused on enterprise applications in Kenya, and Pixxel, which is developing high-resolution hyperspectral imaging satellites. GrowX Ventures has also seen notable exits, including Wellthy Therapeutics and Doxper, which highlight their successful investment strategy. Key team members at GrowX Ventures include partners like Manu Rikhye and Sheetal Bahl, who bring extensive experience and passion for working with talented founders addressing large and complex problems. The firm’s approach involves not just financial investment but also strategic support to help startups scale and succeed. GrowX Ventures primarily invests in India, with a few investments in the United States, and is known for its collaborative approach, often co-investing with other prominent venture capital firms like Blume Ventures and Lightspeed Venture Partners.

GSR Ventures, founded in 2004, is a global venture capital firm with over $3.7 billion in assets under management. The firm focuses on early-stage technology companies developing AI-enabled enterprise software, consumer platforms, and healthcare technology. GSR Ventures has a notable track record with investments in companies like Didi Chuxing, Ele.me (acquired by Alibaba), Qunar (NASDAQ: QUNR), and Xiaohongshu. The firm typically invests in transformative companies that have the potential to make a significant impact in their sectors. GSR Ventures operates across the United States, China, and East Asia, supporting its portfolio companies with a team of experienced founders, engineers, physicians, and enterprise executives. Their approach emphasizes deep industry expertise and active partnership with entrepreneurs. Key team members include co-founder and managing partner Richard Lim, and partner Justin Norden, who focuses on digital health investments. GSR Ventures' strategy involves making significant early-stage investments and providing ongoing support as these companies scale​​. For startups seeking investment from GSR Ventures, it is crucial to demonstrate strong potential for innovation and sector disruption. The firm values clear, compelling pitches and prefers engagements through its extensive network of industry connections.

Gotham Green Partners, founded in 2017 and based in Santa Monica, California, is a private equity firm specializing in the cannabis sector and related industries. The firm leverages decades of institutional investing and operational experience to support its portfolio companies with strategic guidance, operational expertise, and flexible capital solutions. Their investments span various stages of growth, including venture capital, growth equity, structured credit, and special situations. Gotham Green Partners has made significant investments in notable companies such as MedMen, a vertically integrated cannabis operator with marquee stores in high-profile locations, and iAnthus, which operates across multiple states with a focus on CBD products. Other prominent portfolio companies include Lord Jones, known for its luxury CBD products, and Jane Technologies, which offers retail software solutions for the cannabis industry. The firm has a strong track record of successful exits, including the sale of Lord Jones to Cronos Group and the acquisition of HERBL, a major cannabis distributor in California. Gotham Green Partners is led by Founder and Managing Partner Jason Adler, who brings extensive experience in institutional capital allocation and strategic investment​.

GTMfund is an early-stage venture capital fund that focuses on investing in B2B SaaS companies. Established in 2020 and headquartered in Austin, Texas, the fund leverages a network of over 350 go-to-market (GTM) leaders from top tech companies like Salesforce, LinkedIn, Zoom, and Snowflake to provide strategic support and drive growth for its portfolio companies​. GTMfund has made 115 investments across various sectors including big data, artificial intelligence, fintech, and productivity tools. Notable portfolio companies include CaptivateIQ, Census, Demostack, Mutiny, and Vanta. These investments are often co-led with other top-tier venture firms like Sequoia, Accel, and a16z​. The fund's unique value proposition lies in its ability to offer extensive go-to-market expertise and a strong network of experienced executives who assist startups with distribution, revenue generation, and strategic advice. This support helps startups scale efficiently and effectively from early stages to IPO. For startups looking to partner with GTMfund, demonstrating strong product-market fit and readiness to accelerate growth is crucial. The fund provides significant value through its GTM playbooks, recruitment support, and a community of top-tier GTM leaders​.

H/L Ventures is a New York-based venture capital firm, established in 2009, that focuses on investing in early-stage companies with a commitment to growth, impact, and diversity. The firm operates as a company-building ecosystem, offering hands-on support to founders through its model of "Daily Active Engagement," helping startups overcome common early-stage challenges. H/L Ventures believes that businesses which create positive societal impact are more likely to succeed, and it particularly supports diverse founding teams, with 84% of its portfolio companies being led by underrepresented groups. H/L Ventures invests across a variety of sectors including climate and energy, healthcare, fintech, and the future of work. Recent investments have included companies like Myavana, a digital haircare assistant powered by AI, and Loliware, a seaweed-based biomaterials company focused on replacing single-use plastics. The firm’s portfolio reflects its mission of investing in businesses that provide innovative solutions to pressing global issues, such as sustainability and equity. With over 100 investments made, H/L Ventures manages a portfolio that spans from pre-seed to growth-stage companies. It recently closed its second early-stage fund, CityRock Fund II, raising $24 million to continue its focus on high-impact, diverse startups that address significant global challenges.

H&M Group Ventures, previously known as H&M CO:LAB, is the corporate venture capital arm of H&M Group. Founded in 2015 and headquartered in Stockholm, H&M Group Ventures invests globally in early to growth-stage companies. The firm focuses on three key areas: sustainable fashion, new retail technologies, and services that enhance retail and consumer experiences. H&M Group Ventures seeks to foster innovation by providing both capital and industry expertise. The firm partners with entrepreneurs who have the potential to revolutionize fashion and retail, with investments that help build circular business models, decarbonization technologies, and consumer-driven platforms. Notable investments include Kintra Fibers, a sustainable materials startup, and Rondo Energy, which develops clean energy solutions for retail operations. The firm’s strategy is built on creating long-term value by combining H&M’s global retail expertise with the innovative solutions of its portfolio companies. H&M Group Ventures focuses on minority ownership and provides not only financial backing but also strategic support to help companies scale within global markets.

Hack VC is a web3-focused venture capital firm headquartered in Incline Village, Nevada, and founded in 2021. The firm specializes in investing in early-stage startups within the cryptocurrency, AI, and blockchain sectors. Hack VC has raised significant funds, including a $150 million venture fund, bringing their total assets under management to approximately $425 million. Notable investments by Hack VC include Jasper AI, a generative AI copilot for enterprises, and Sui by Mysten Labs, which focuses on the secure MOVE programming language for blockchains. Hack VC also supports the decentralized wireless network Helium and Ethereum infrastructure firm Consensys. Their investment strategy targets projects that enhance the usability, scalability, and security of web3, aiming to support the next generation of web3 infrastructure. The firm leverages its hack.labs platform to engage with the protocols they invest in, providing liquidity and support to DeFi pools and other blockchain initiatives. Additionally, Hack VC organizes hackathons and conferences through their hack.summit community, fostering a global network of developers and innovators.

Hadean Ventures is a European life science venture capital firm headquartered in Oslo, Norway, with an additional office in Stockholm, Sweden. They focus on investing in life science startups across Europe, particularly in the Nordics and German-speaking countries. The firm manages approximately EUR 230 million in assets through its two main funds, Hadean Capital I and Hadean Capital II, which collectively exceed their initial targets due to strong investor support. The firm's investment strategy spans across pharmaceuticals, biotech, medtech, diagnostics, and digital health, targeting early to mid-stage companies with the potential to address unmet medical needs. Notable investments include Alex Therapeutics, Arthex Biotech, Complement Therapeutics, Emergence Therapeutics, Ribbon Biolabs, and TargED. Their first successful exit was the acquisition of Emergence Therapeutics by Eli Lilly in 2023. Hadean Ventures is led by Managing Partners Ingrid Teigland Akay and Walter Stockinger, who bring extensive experience in life sciences and venture capital. The team is recognized for its hands-on operational management and strategic guidance, fostering significant advancements in the healthcare sector. For startups seeking investment from Hadean Ventures, it is advantageous to demonstrate strong innovation in addressing critical healthcare challenges and to align with their focus on transformative life science solutions​.

Hala Ventures is a prominent Saudi-based venture capital firm that focuses on investing in early-stage tech startups, primarily within the MENA region. Founded in 2018, the firm emphasizes sectors such as fintech, e-commerce, SaaS, and logistics. Some of their notable investments include Telfaz11, a creative media studio, and Kaso, a B2B food procurement platform. They actively support startups from Saudi Arabia and neighboring countries, including Egypt and Jordan. Hala Ventures typically targets startups that have achieved sustainable revenue and are scaling their operations. They offer both capital and hands-on strategic support, positioning themselves as a long-term partner for growth. The firm’s leadership, including founding partner Hussain Almarhoon, brings deep expertise in finance and entrepreneurship, ensuring robust guidance for portfolio companies. Their approach to venture investment is rooted in empowering startups through personalized mentorship and building strong ecosystems in the GCC. With a strong track record in fintech and other tech verticals, Hala Ventures continues to be a key player in the region’s burgeoning startup ecosystem.

Halley Venture Partners, founded in 2017 and based in San Francisco, is a venture capital firm that specializes in investing in the legal cannabis and hemp industries. The firm, led by Managing Director Steve Schuman, focuses on early-stage investments, particularly in technology and medical companies that are driving innovation within the cannabis sector. With a background in public and private equity, Schuman and his team bring significant expertise to their portfolio, which includes companies like Willow Industries, Front Range Biosciences, and PathogenDx. Halley Venture Partners typically invests in Seed, Series A, and Series B rounds, supporting startups that are developing scalable solutions and transformative technologies in the cannabis space. The firm is dedicated to building highly scalable businesses, leveraging deep industry knowledge and a hands-on approach to guide companies through the complexities of the rapidly evolving cannabis market. The team at Halley Venture Partners includes experienced professionals like Aaron Taffet, who brings a strong background in private equity and cannabis operations, and advisors such as Ephraim Lindenbaum and Lauren Fraser, who contribute valuable insights from their extensive experience in venture capital and cannabis distributio.

Halogen Ventures, founded by Jesse Draper in 2015, is an early-stage venture capital firm based in Los Angeles. The firm focuses on investing in female-led consumer technology companies and strategic B2B software sectors. Halogen Ventures has made significant strides with notable investments in companies such as Babylist, Flex, and Ellevest. The firm has raised a total of $31.4 million across its funds and has invested in over 111 companies, achieving 12 successful exits. Their investment strategy includes providing not just capital but also strategic support to help companies grow and scale effectively. They assist with network building, brand exposure, talent acquisition, and subsequent funding rounds. Halogen Ventures is particularly focused on the consumer technology market, driven by the fact that women make 80% of household purchasing decisions. This strategic focus has led to their portfolio companies generating over $10 billion in market value.

Harlem Capital is an early-stage venture capital firm based in New York, dedicated to changing the face of entrepreneurship by investing in 1,000 diverse founders over the next 20 years. Founded in 2015, Harlem Capital focuses on women and minority entrepreneurs, aiming to close the venture capital gap for underrepresented founders. The firm has raised significant capital, with its second fund, Harlem Capital Partners Venture Fund II, closing at $134 million, surpassing its initial target. This fund allows Harlem Capital to invest in 45 companies, primarily at the early seed stage, and maintains a commitment to minority and women founders. The firm targets industries like enterprise and consumer technology and aims for 10%+ ownership stakes in its investments. Harlem Capital's approach includes initiatives like "Culture Carry," which allows founders to share in the fund's carry, promoting a collaborative ecosystem among its portfolio companies. The firm's portfolio includes over 60 investments across various sectors and cities, featuring companies such as Pangaea, CashDrop, and Wellory. The team is led by co-founders Henri Pierre-Jacques and Jarrid Tingle, along with a dedicated group of investors and associates who bring diverse backgrounds and expertise to the firm. Harlem Capital's mission-driven approach and strategic investments aim to foster long-term growth and success for underrepresented founders in the venture capital landscape.

Harrison Metal is a venture capital firm based in San Francisco, founded in 2008 by Michael Dearing. The firm focuses on early-stage investments in technology-driven companies, particularly in the consumer, business services, and developer tools sectors. Over the years, Harrison Metal has attracted a small group of limited partners, including university endowments, charitable trusts, and pensions. Michael Dearing, the founder and General Partner, has a robust background, having worked at eBay, The Walt Disney Company, and Bain & Company before establishing Harrison Metal. He also serves as a Consulting Associate Professor at Stanford University, where he shares his extensive experience in business history and management through various classes offered by Harrison Metal. The firm is notable for its disciplined investment strategy and its support of startups through six funds, providing not just capital but also strategic guidance and operational expertise to help founders navigate the complexities of growing a business.

Hashed is a leading venture capital firm specializing in blockchain technology and Web3 startups. With headquarters in Seoul and offices in Singapore, San Francisco, and Bengaluru, the firm is deeply committed to decentralization and its potential to transform global economies. Hashed supports early-stage founders building innovative decentralized applications (dApps), tools, and infrastructure across industries like finance, gaming, and entertainment. Some of its notable portfolio companies include Aptos, a blockchain infrastructure project, and Republic, a platform for investing in startups and crypto. Hashed is more than just an investor—they act as ecosystem builders, offering hands-on strategic support to their portfolio companies. They also run subsidiaries like Hashed Emergent, which focuses on emerging markets, and UNOPND, an incubator for early Web3 startups. Hashed regularly hosts major blockchain events, including Korea Blockchain Week (KBW), which has become one of Asia’s largest blockchain gatherings. The firm's global network and commitment to fostering decentralized communities have helped them lead the charge in Web3 innovation.

Hatteras Venture Partners, based in Research Triangle Park, North Carolina, focuses on seed and early-stage investments in biopharmaceuticals, medical devices, diagnostics, healthcare IT, and related areas in human medicine. Founded in 2000, the firm has grown significantly and now manages approximately $450 million across multiple funds​. The firm aims to build transformational companies that benefit patients and healthcare professionals, with a strong emphasis on investing in innovative life science companies. Notable investments include G1 Therapeutics, Clearside Biomedical, and GeneCentric​. Hatteras Venture Partners also manages the Venture Capital Multiplier Fund (VCMF), a $60 million fund that co-invests with other venture capital firms to support high-growth companies in North Carolina​. The firm has a proven track record, leveraging relationships with major healthcare institutions like UNC-Chapel Hill, Duke University, and Vanderbilt University to foster innovative startups​.

HAX is a venture capital firm focused on hard tech startups, investing in areas like robotics, industrial automation, and sustainability. As part of the larger SOSV ecosystem, HAX supports early-stage founders by providing a $250,000 initial investment along with extensive engineering and prototyping resources. The firm operates out of key locations including Newark, NJ, and Shenzhen, China, offering access to fabrication tools like CNC machining and 3D printing for rapid prototyping. With over 250 startups in its portfolio, HAX has backed notable companies like Formlabs, a leader in 3D printing, and Renovate Robotics, which focuses on automating solar installations. HAX typically invests in pre-seed and seed rounds and follows up with additional funding up to $3 million as startups grow. They are especially hands-on, working closely with founders to iterate and develop market-ready products. If you're a founder working on a hard tech solution and looking for mentorship and investment, HAX's global network and resources can accelerate your startup's journey from prototype to product.

Haystack is an early-stage venture capital firm based in San Francisco, known for backing outlier founders at the earliest stages of their startups. The firm typically invests in pre-seed, seed, and Series A rounds, with investment amounts ranging from $250,000 to $1.5 million. Haystack's investment focus includes sectors such as analytics, data, AI, cloud infrastructure, developer tools, distributed workforce, and other enterprise technologies. Founded by Semil Shah, Haystack has built a reputation for supporting exceptional founders through a robust network of advisors, customers, and talent. The firm's portfolio boasts notable companies like DoorDash, Instacart, Canva, and Dropbox, reflecting its success in identifying and nurturing high-potential startups.

Headline is a globally recognized venture capital firm with a robust track record in early-stage investments across various industries. Founded in 1999 and headquartered in San Francisco, Headline has established a significant presence in Europe, Asia, and Latin America. Their investment portfolio includes prominent names such as Sonos, Bumble, Farfetch, and SEMrush, highlighting their knack for identifying and nurturing market leaders in sectors ranging from fintech to consumer services and digital health. Headline's strategy is built on a unique technology-driven approach, leveraging proprietary platforms like EVA and ATHENA to identify and evaluate promising startups with precision. EVA uses sophisticated algorithms to monitor over 10 million companies, ensuring early discovery of high-potential ventures, while ATHENA helps in quick and accurate underwriting by analyzing company data to forecast growth trajectories and capital needs. The firm operates regionally-focused funds, including Headline US VII, Headline EU VII, and Headline Brazil III, which collectively raised $954 million in 2022 to support early-stage technology companies. This regional focus allows them to stay close to local markets and trends while maintaining a global perspective and infrastructure. Headline's commitment to diversity is evident, with a strong emphasis on investing in underrepresented founders and creating inclusive work environments. Their team of over 50 investment professionals operates from major cities worldwide, including San Francisco, Berlin, Paris, São Paulo, and Tokyo, bringing a wealth of local and global expertise to their investments. Overall, Headline’s innovative approach and global reach make them a formidable partner for startups aiming to scale and succeed on an international stage.

Heal Capital is a prominent venture capital fund based in Berlin, Germany, that focuses on early-stage investments in the digital health sector. Launched with strong backing from Germany's private health insurance sector, the fund is dedicated to driving digital transformation in healthcare by supporting innovative startups across Europe. Heal Capital typically invests between €1.5 million and €5 million in Seed to Series A rounds, targeting companies that develop solutions to improve patient care and healthcare delivery efficiency. The firm’s investment strategy is centered around digital health, med-tech, and biotech, with a preference for scalable solutions that integrate healthcare with cutting-edge technology. Heal Capital also leverages an extensive network of industry leaders and healthcare professionals to provide strategic guidance to its portfolio companies. Notable companies in Heal Capital’s portfolio include Apheris, a platform for collaborative data ecosystems; CereGate, a company developing computer-brain interfaces; and Gleamer, which uses AI to enhance radiology workflows.

HTH (Health Technology Holding) is a Milan-based venture capital firm specializing in investments within the life sciences sector. Established in 2020 as part of ZCube-Zambon Research Venture, HTH focuses on backing early-stage deep tech startups dedicated to improving human health. The firm’s investment strategy spans a broad range of verticals, including biotech, medtech, digital health, femtech, diagnostics, and consumer healthcare. HTH is particularly interested in companies leveraging cutting-edge technologies such as AI, advanced biotech, and novel medical devices that address unmet needs in healthcare. Their portfolio includes pioneering companies like SOM Biotech, which uses AI to repurpose existing drugs, and Neurofenix, a platform that aids in neurological rehabilitation through innovative sensor technology. The team at HTH is composed of experts from various scientific and technical backgrounds, including statisticians, pharmacists, and biotechnologists. This diverse expertise allows them to provide not only capital but also strategic guidance to their portfolio companies. They focus on fostering innovation that has the potential to make a significant impact on global health, with a special emphasis on scalable and sustainable solutions. HTH’s investments typically range from early to mid-stage companies, reflecting their commitment to nurturing breakthrough innovations from the ground up. The firm also actively collaborates with a wide network of healthcare companies and partners to drive the development and commercialization of transformative health technologies.

HealthCare Ventures is a life science-focused venture capital firm founded in 1985 and headquartered at 47 Thorndike Street in Cambridge, Massachusetts. Over more than 35 years, the firm has invested $1.6 billion in more than 100 therapeutic, diagnostic, device, and healthcare technology companies, establishing itself as one of the longest-running healthcare-dedicated VC firms in the United States. Harold Werner serves as Managing Director, and the firm employs approximately 11 people. HealthCare Ventures focuses specifically on pre-clinical or early clinical stage companies with transformative potential in patient care, deploying check sizes in the $3 million to $10 million range across Seed, Series A, and Series B rounds and leading rounds. The firm has made at least 32 tracked investments according to public databases. Portfolio sectors span therapeutics, diagnostics, medical devices, and healthcare technology. A recent notable portfolio exit was Paige, an AI-powered cancer diagnostics company, which exited on August 22, 2025. HealthCare Ventures takes a hands-on approach that goes beyond providing capital: the team actively helps manage portfolio companies, providing operational guidance, strategic input, and scientific expertise throughout the development journey from pre-clinical work to commercialization. The firm's nearly four decades of continuous operation in life science venture investing give it institutional knowledge and relationships across the clinical, regulatory, and commercial ecosystem that span multiple full innovation cycles in biotechnology and medical devices.

HealthQuad is India's leading healthcare-focused venture capital fund, co-founded by Quadria Capital in 2016. The firm targets early-stage investments in companies that are poised to transform the healthcare sector through technological innovation and improved accessibility. HealthQuad's mission is to enhance healthcare affordability, accessibility, and quality in India. The fund recently closed its second fund, HealthQuad Fund-II, raising $162 million, more than double its initial target. This fund focuses on investing in companies that digitize the healthcare value chain, addressing significant gaps revealed during the COVID-19 pandemic, such as the surge in teleconsultations and e-pharmacy usage. HealthQuad's portfolio includes innovative companies like Medikabazaar, THB, HealthifyMe, and ImpactGuru. These investments highlight the fund's commitment to supporting digital health platforms and integrated healthcare financing solutions​. The fund plans to invest in 12-14 companies with individual cheque sizes ranging from $5 to $20 million. Led by co-founders Abrar Mir, Amit Varma, and Charles-Antoine Janssen, HealthQuad leverages extensive industry experience and a robust network to guide its portfolio companies through growth and innovation in the healthcare sector.

HealthQuest Capital, established in 2012 and headquartered in Redwood City, California, is a private asset firm dedicated to providing growth capital to transformative healthcare companies. Their investment focus spans medical devices, diagnostics, digital health, healthcare IT, and innovative services. They prioritize commercial-stage companies that demonstrate proven products or services and require resources to scale effectively. HealthQuest typically invests between $20 million and $100 million per company, often leading the investments and syndicating when necessary. The firm is committed to enhancing patient outcomes and healthcare delivery efficiency, managing approximately $2 billion in assets. The leadership team, spearheaded by founder Garheng Kong, consists of experienced professionals with a combined 300+ years in healthcare investing and operations. Key team members include Randy Scott, Sam Brasch, Sharath Reddy, and Conrad Wang. The firm also boasts a distinguished Board of Advisors featuring notable industry leaders like Regina Benjamin, former U.S. Surgeon General, and Bruce Broussard, CEO of Humana. HealthQuest's portfolio includes companies like Alcresta Therapeutics, Everlywell, Inbound Health, Pulmonx, and TigerConnect. They actively seek investments that offer innovative healthcare solutions and possess the potential for significant growth and impact.

Healthy Venture Capital (Healthy VC) is a premier early-stage investment firm focused on health tech and life sciences startups. With notable investments in companies like Hubble Telemedical and Lineus Medical, Healthy VC is at the forefront of healthcare innovation. The firm targets sub-industries such as telehealth, health data analytics, and digital health platforms, emphasizing technology-driven solutions to enhance patient care. Based in the U.S., Healthy VC invests globally, typically at pre-seed, seed, and series A stages, and often leads funding rounds to foster early growth. The team, including industry veterans like Sean Mendy and Ian Beadle, offers not only financial support but also strategic guidance and access to a broad network of healthcare leaders. For startups seeking investment, it’s crucial to demonstrate a strong technological foundation and a vision for transformative healthcare improvements. Healthy VC values innovations with significant impact potential and scalability in the healthcare sector​.

Heda Ventures is a venture capital firm established in 2008 with headquarters in San Jose, California, and additional operations in Hangzhou, China. The firm specializes in early-stage investments in cutting-edge industries, particularly focusing on biotechnology, healthcare, and the technology, media, and telecommunications (TMT) sectors. Heda Ventures has built a robust portfolio of over 67 investments, working closely with startups that are driving innovation in areas such as diagnostic equipment, drug discovery, semiconductors, and medical supplies. The firm is known for its strategic approach to investment, aiming to support companies with high growth potential by providing not just capital but also guidance and access to its extensive global network. This approach helps portfolio companies scale effectively and achieve market success. Heda Ventures has also been involved in significant exits, including companies like Just - Evotec Biologics and DeepMap, which highlight its successful track record in the venture capital space. With a deep commitment to fostering innovation, Heda Ventures continues to focus on transformative technologies that address critical challenges in healthcare and technology, positioning itself as a key player in the venture capital landscape. The firm's ability to bridge the gap between the U.S. and Chinese markets further enhances its capability to nurture and grow companies on a global scale.

Helicase Venture is an early-stage life sciences venture capital firm founded in 2018 and headquartered in Boston with an additional presence in San Francisco. The firm focuses on innovative life sciences and Bio-IT companies — businesses at the intersection of engineering, health, and AI — with a mission to work alongside early-stage teams as they navigate developmental milestones and bring therapies to patients. The two-partner team is led by Dr. Richard Tsai, a Founding Member who previously served as a Partner at BioEngine Capital where he headed life science investments and was involved in founding multiple companies, and Dr. Joy Lee as Partner. The firm leads rounds and targets Seed and Series A investments with initial commitments of $1 to $5 million. Helicase manages one fund, Helicase Venture Fund I, which has backed eight companies across the United States, Austria, and China, producing two IPOs and three acquisitions. Notable portfolio companies include AbSci (AI-driven drug and target discovery using deep learning and synthetic biology, which completed a Nasdaq IPO in July 2021 at a $1.45 billion market capitalization), Tangible Science (contact lens technology spanning consumer to smart applications), and Totient (AI-driven biotech leveraging tertiary lymphoid structures for novel tissue-specific antigens and high-affinity antibody therapeutics, which was subsequently acquired by AbSci). Helicase makes investment decisions as a team, with each partner contributing domain expertise across biological sciences and computational technologies, supplemented by a network of scientific advisors. The firm's focus on companies working at the frontier of biology and computation reflects a thesis that the most transformative near-term progress in patient care will come from founders who can move fluidly between wet lab science and data-driven discovery.

Hemisphere Ventures is a venture capital firm based in Mercer Island, Washington, that focuses on pre-seed and seed-stage investments in cutting-edge technologies. Founded in 2014, the firm primarily invests in sectors like software, biotech, space tech, robotics, drones, and nanotechnology. Their portfolio includes companies like PlanetiQ, Axiom, and Finless Foods, which are leading advancements in space exploration, synthetic biology, and sustainable food production. Hemisphere Ventures actively seeks out companies that are pushing the boundaries of science and technology, often in niche but high-potential areas like space travel, advanced AI, and biotech innovations. They aim to provide not just capital but strategic guidance to help startups scale rapidly. The firm is known for supporting companies that have strong potential to reshape industries and create long-term societal impact. The team at Hemisphere Ventures consists of experienced founders, operators, and investors, who bring decades of expertise in building and scaling businesses across various industries. Their investments reflect a deep interest in transformative technologies with a global reach, helping startups grow at an unprecedented pace.

Henkel Tech Ventures, established in 2016 and headquartered in Düsseldorf, is the corporate venture capital arm of Henkel Adhesive Technologies. The fund primarily targets startups in Europe, North America, and the Asia-Pacific region, focusing on innovative solutions in adhesives, sealants, and functional coatings. Notable investments include ioTech, which developed a high-speed, multi-material additive manufacturing technology, and 3RT, which has created a robotic process for converting wood residue into high-quality hardwood products. Henkel Tech Ventures invests up to 5 million euros in early-stage startups, offering not only capital but also access to Henkel’s extensive global network and technical expertise. Their strategy emphasizes long-term collaboration, leveraging Henkel’s market and technology know-how to drive mutual growth. The fund looks for scalable technologies that complement Henkel’s existing portfolio and foster sustainable innovations. The team is led by Paolo Bavaj, Head of Corporate Venturing, who emphasizes scouting for technologies that enhance Henkel's core markets, such as electronics and engineered wood solutions. Startups benefit from mentorship by Henkel's top management and consulting by their technology experts, ensuring they receive both strategic and operational support. Recent investments include Direct-C, which specializes in hydrocarbon leak detection, and Smartz AG, which offers IoT solutions for adult care. Henkel Tech Ventures is a crucial partner for startups looking to revolutionize industrial applications through advanced materials and sustainable technologies.

Heritas Capital is a Singapore-based private equity and venture capital firm that focuses on high-growth sectors such as healthcare, education, and technology. Established in 1997, the firm has evolved into a key player in impact investing, driven by its philosophy of “Invest with Purpose, Impact Across Generations.” The firm manages a diverse portfolio of investments, backing companies that aim to create positive social and environmental change while delivering sustainable financial returns. Heritas Capital actively supports ventures across Asia through a multi-stage investment platform, targeting seed to growth stages. It has been involved in significant funding rounds for companies like Holmusk, Hummingbird Bioscience, and Cakap, addressing needs in areas such as digital health, biotech, and edtech. The firm also partners with organizations like SEEDS Capital to co-invest in promising startups, helping scale impact-focused innovations. Heritas Capital’s approach includes a strong commitment to improving access to healthcare and lifelong learning while leveraging technology to drive efficiencies in industries like foodtech and urban solutions. By aligning with partners who share their vision, Heritas ensures that their investments have a long-lasting, generational impact.

Hellman & Friedman (H&F) is a prominent private equity firm with a long history of making large-scale investments in high-quality growth businesses. Founded in 1984, the firm is headquartered in San Francisco, with additional offices in New York and London. H&F focuses on a concentrated investment strategy, deploying significant capital in a limited number of sectors where it has deep expertise, such as software and technology, financial services, healthcare, consumer and retail, and other business services​. The firm recently closed its tenth fund, Hellman & Friedman Capital Partners X (HFCP X), with commitments totaling $24.4 billion, making it one of the largest private equity funds ever raised. This fund will enable H&F to continue its strategy of targeting large-scale investments in outstanding growth businesses, primarily in North America and Europe. H&F is known for its collaborative approach, working closely with management teams to develop and implement value creation plans tailored to each company's specific needs. The firm prides itself on its long-term investment horizon and alignment of interests with its portfolio companies, fostering a culture of mutual success.

Hillhouse Investment Group is a leading global investment firm, founded in 2005 by Zhang Lei. Based in Hong Kong with additional offices in Beijing, Hillhouse focuses on long-term investments across public and private markets. The firm’s strategy revolves around building sustainable, high-quality businesses, with particular emphasis on healthcare, consumer, industrials, and technology sectors. Initially starting with a $20 million investment from Yale University's endowment fund, Hillhouse has grown into a financial giant managing over $60 billion in assets. Known for its rigorous research and hands-on approach, the firm partners with management teams to drive innovation and growth in its portfolio companies. Notable investments include major players like Tencent, Zoom, and JD.com. Hillhouse is also active in private equity and venture capital, making significant contributions to early and growth-stage companies across Asia, North America, and Europe. Its venture arm, GL Ventures, supports early-stage technology and healthcare startups. The firm is recognized for its ability to anticipate market trends and build long-term value in companies that can withstand evolving economic landscapes. With a reputation for aligning closely with management teams and maintaining a disciplined investment strategy, Hillhouse continues to be a powerful force in global markets.

Hiventures, a Hungarian state-owned venture capital fund, is renowned for its extensive portfolio and dynamic investment strategy. With a focus on supporting startups from pre-seed to growth stages, Hiventures has made over 770 investments across various sectors, including software services, cloud computing, and cybersecurity. Notable investments include Access4you, iBar Experience, and Surviot Monitoring, showcasing their commitment to innovation in diverse industries. Geographically, Hiventures primarily invests within Hungary, emphasizing the growth of the local entrepreneurial ecosystem. Their strategy involves flexible investment conditions and a quick adaptation to the needs of startups, making them a preferred partner for early-stage ventures. Hiventures typically invests around $983,000 per round, actively leading many of these investments. They maintain a high engagement level, with an average of 30.96 rounds per year, peaking in 2021. The fund's team, including key figures like CEO Eszter Jandrasics and Senior Investment Manager Ádám Horváth, brings deep expertise in venture capital and business development. For startups looking to approach Hiventures, it's beneficial to highlight innovative solutions and scalability. They prefer well-prepared pitches that align with their focus on fostering technological advancements and economic growth in Hungary.

Hong Kong Science and Technology Parks Corporation (HKSTP) is the leading innovation and technology (I&T) ecosystem in Hong Kong. Established in 2001, HKSTP fosters tech startups and industry growth, focusing on sectors like healthtech, AI and robotics, fintech, and smart city innovations. The corporation manages a network that includes the Hong Kong Science Park, InnoCentre, and InnoParks, supporting over 1,700 companies and 14,000 R&D professionals. HKSTP offers full-cycle support to startups, from incubation and prototyping to funding and commercialization. They manage the HKSTP Venture Fund, a HK$1 billion asset fund, to support high-growth tech ventures, and have groomed multiple unicorns within their ecosystem. With strong connections to the Greater Bay Area, HKSTP also helps companies expand into mainland China. Their resources include world-class R&D labs, co-working spaces, advanced manufacturing centers, and a broad investor network. HKSTP’s mission is to drive collaboration, accelerate innovation, and cultivate talent for Hong Kong and the broader region, positioning the city as a leading global innovation hub.

HLM Venture Partners is a leading venture capital firm focused exclusively on healthcare technology and services. Based in Waltham, Massachusetts, the firm has been at the forefront of healthcare investment for over 40 years, deploying more than $400 million across 100+ companies. HLM targets companies that are capital-efficient and patient-centric, helping them scale by offering not just financial support, but strategic guidance and deep industry expertise. The firm focuses on key healthcare sectors like healthcare IT, value-based care, medical devices, and patient engagement. HLM is particularly interested in companies addressing critical issues like expanding access to care, behavioral health innovations, and solutions for provider shortages. Notable investments include Teladoc, a pioneer in telemedicine, NeuroFlow, which leverages AI for mental health support, and mPulse Mobile, a leader in mobile patient engagement solutions​. HLM prides itself on being a first-call partner for its portfolio companies, providing hands-on support to help them navigate complex regulatory landscapes and reach their growth potential. Their extensive healthcare network gives their startups unrivaled access to key decision-makers across the care continuum. Over the years, HLM has created significant value for both its portfolio companies and investors, facilitating the growth of several iconic healthcare brands. By aligning themselves with bold, principled management teams, HLM continues to drive transformative healthcare solutions that improve both quality and cost of car.

HOF Capital is a global venture capital firm headquartered in New York, focused on investing in transformative technology companies from idea to IPO. With support from over 70 influential family offices, global corporations, and institutions, HOF provides startups with more than just capital—they offer strategic partnerships that open doors to new markets, customer bases, and operational growth. Their portfolio features industry-leading companies such as Alibaba, Epic Games, UiPath, and ASAPP. HOF Capital specializes in sectors like fintech, deep tech, healthcare, and logistics, making investments from pre-seed to late-stage rounds. The firm’s approach emphasizes long-term value creation, guiding entrepreneurs through various growth stages with business development, sales, and fundraising support. With offices in New York, London, and San Francisco, and a team of investors spread across key global regions, HOF operates as a bridge between startups and large-scale enterprises. Co-founded by Hisham Elhaddad, Onsi Sawiris, and Fady Yacoub, HOF leverages its vast network of partners, including industry giants like Visa, Nvidia, and Daimler, to provide startups with critical resources and strategic advice. Their multi-stage investment strategy, combined with deep industry knowledge and a vast network, helps startups scale quickly while navigating complex challenges in highly competitive environments.

Homebrew is a unique venture capital fund dedicated to early-stage investments, founded by Hunter Walk and Satya Patel. With a focus on seed-stage startups, Homebrew partners with mission-driven founders to build transformative companies. They have a notable portfolio including companies like Plaid, Mercury, and Winnie, reflecting their commitment to impactful ventures. Primarily investing in software and technology sectors, Homebrew targets industries like fintech, AI, robotics, and healthcare. Their geographic focus is predominantly in North America, supporting startups across the U.S. and Canada. Homebrew's investment strategy emphasizes a hands-on approach. They typically lead or co-lead seed rounds, with initial investments ranging from $250k to $800k. Homebrew is known for their deep involvement with portfolio companies, offering not just capital but also strategic counsel, operational support, and access to their extensive network. Recently, Homebrew transitioned to an evergreen investment model, utilizing their own capital to maintain flexibility and alignment with founders' needs. This shift allows them to engage with startups at various stages without being constrained by traditional fund structures. The team at Homebrew includes industry veterans like Hunter Walk and Satya Patel, both former Google product executives. They are based in Burlingame, California, and are recognized for their commitment to fostering strong, supportive relationships with entrepreneurs.

Honeywell is a global technology and manufacturing leader, delivering a diverse range of products and services across various sectors. In aerospace, Honeywell provides advanced avionics, propulsion, and aircraft management systems, enhancing safety and efficiency for commercial and defense aircraft. Their building technologies division offers smart solutions for energy efficiency, security, and automation, contributing to more sustainable and connected buildings. In the realm of performance materials and technologies, Honeywell develops high-performance chemicals, materials, and industrial software, supporting a wide array of industries from oil and gas to pharmaceuticals. The safety and productivity solutions division focuses on providing innovative safety equipment, advanced software, and workflow automation technologies that boost operational efficiency and worker safety. Honeywell is deeply committed to sustainability, integrating environmental considerations into their product development and operational strategies. They aim to reduce their carbon footprint and help customers achieve their sustainability goals through cutting-edge technologies and solutions. Through continuous innovation, strategic partnerships, and a strong emphasis on quality and reliability, Honeywell strives to drive progress and create value for customers worldwide, shaping a more efficient, safe, and sustainable future.

Hoxton Ventures is a London-based early-stage venture capital firm known for backing some of Europe’s most successful startups, including Deliveroo, Babylon Health, and Darktrace. Founded in 2013, Hoxton focuses on investing in disruptive technology companies with the potential to become global leaders in their sectors. The firm primarily targets startups at the pre-seed and seed stages, helping them scale with both financial support and strategic guidance. Hoxton Ventures has a strong track record of identifying innovative companies across diverse industries such as fintech, healthcare, AI, and enterprise software. Their portfolio includes notable investments that have either gone public or reached unicorn status. The firm operates as a partner-only team, ensuring that founders receive direct attention and mentorship from experienced investors who have backgrounds in building and scaling companies themselves. With a proactive approach, Hoxton leverages deep industry expertise and a global network to support the growth of its portfolio companies. The firm typically invests above €3 million and provides operational support to help startups navigate their early stages, positioning them for long-term success in the competitive European startup ecosystem.

HP Tech Ventures, established in 2016, is the venture capital arm of HP Inc., designed to fuel innovation by strategically investing in early-stage startups that are poised to disrupt the tech landscape. The firm’s investment focus spans a variety of high-impact areas, including generative AI, edge computing, hybrid work solutions, 3D printing, and sustainability. These sectors align with HP's broader vision of shaping the future through transformative technologies. HP Tech Ventures not only provides capital but also offers its portfolio companies access to HP’s global resources, including one of the world’s largest channel and distribution networks, deep technological expertise, and a vast manufacturing and supply chain infrastructure. This support helps startups scale rapidly and achieve significant market impact. The firm’s portfolio is diverse, including companies like Mojo Vision, a pioneer in micro-LED technology, and Owl Labs, which focuses on solutions for hybrid work environments. HP Tech Ventures has also seen successful exits, such as the acquisition of Mobalytics, a gaming analytics platform, by Tencent, and Voxel8, a 3D printing startup, by DSM. These exits demonstrate HP Tech Ventures' ability to identify and nurture companies that deliver substantial returns and technological advancements. The team at HP Tech Ventures, led by Andrew Bolwell, Angelo Del Priore, and others, brings extensive experience in both the technology and venture capital sectors. They actively engage with portfolio companies, offering strategic guidance and leveraging HP’s vast network to accelerate growth. With investments primarily in the U.S. and Israel, HP Tech Ventures continues to be a key player in driving innovation across the tech industry.

High-Tech Gründerfonds (HTGF) is a prominent seed investor based in Bonn, Germany, focused on supporting innovative technology startups in fields such as digital technology, industrial tech, life sciences, and chemistry. Established in 2005, HTGF has invested in over 750 startups and manages more than €2 billion across multiple funds. The firm is a key player in the European venture capital scene, specializing in early-stage investments and follow-on financing. HTGF's approach involves providing more than just capital; they actively assist startups through their vast network, supporting business growth, customer acquisition, and strategic partnerships. The typical investment size starts at €800,000 for seed rounds, with potential follow-on investments of up to €4 million per startup over the company's lifecycle. HTGF has been instrumental in facilitating exits, with over 180 successful exits to date, including IPOs. With the launch of their fourth fund in 2023, HTGF raised nearly €500 million, marking it as their largest fund yet. The firm supports startups not only in Germany but across Europe, as long as they maintain a German presence, helping young companies scale and thrive on the global stage.

Human Capital is a unique venture capital firm based in San Francisco that combines traditional VC investing with a strong focus on talent acquisition and organizational development. Founded by Armaan Ali and Chris Zhang, the firm has a multi-stage investment strategy that spans from seed to growth stages, with a mission to support ambitious founders in building transformative companies. Human Capital has a diverse portfolio, investing in high-potential startups across various sectors, including technology, healthcare, and fintech. Some notable investments include Snowflake, Brex, Livongo, Anduril, and Applied Intuition. The firm emphasizes partnering with founders to build strong teams and scalable businesses, leveraging its extensive network and expertise in recruitment to help companies grow from inception to maturity​/ The firm's approach involves not just capital investment but also providing hands-on support in talent management. They assist portfolio companies in attracting, hiring, and retaining top talent, ensuring that the startups have the human capital necessary to succeed in highly competitive markets​.

Humboldt Fund, founded in 2020 and based in New York, is a venture capital firm focused on investing in the biotech revolution. The fund specializes in early-stage investments in synthetic biology, targeting industries that are transforming the way chemicals, materials, foods, and medicines are made. Humboldt’s mission is to back pioneers in engineering, physical sciences, and life sciences, supporting groundbreaking technologies with the potential to disrupt global markets and solve critical challenges. Key areas of investment include foodtech, healthcare, energy, and advanced materials, with a strong emphasis on synthetic biology and bio-manufacturing. Notable portfolio companies include Metagenomi, Debut Biotech, and Finless Foods, all of which are at the forefront of biotechnological innovation. Humboldt aims to create both economic value and global impact by fostering these revolutionary technologies. Humboldt primarily invests in pre-seed, seed, and Series A stages, with a typical check size ranging from $4M to $36M. The fund is known for supporting companies that contribute to sustainability and technological advancements. By identifying and nurturing trailblazing companies, Humboldt Fund helps bring emerging biotech enterprises to global markets, positioning itself as a key player in the future of biotechnological innovation.

Hummingbird VC, founded in 2010 and based in Antwerp, Belgium, is an early-stage venture capital firm that invests globally, backing founders with groundbreaking ideas. The firm has a strong portfolio with notable investments in companies like Deliveroo, Kraken, and Peak Games. Hummingbird VC focuses on a wide array of industries including fintech, biotech, deep tech, healthcare, and marketplaces, with investments across North America, EMEA, and APAC regions. Hummingbird's investment strategy centers on partnering early with outlier founders and providing unwavering support through the company's lifecycle. They are known for their high conviction and willingness to make substantial investments, often leading funding rounds with check sizes ranging from $500K to over $50M. They prefer a low-friction partnership approach, allowing entrepreneurs to dictate the level of involvement and support needed. Key figures in the team include Barend Van den Brande, the founder, who is based in Belgium, and other partners spread across their international offices. Hummingbird is noted for its patient capital and long-term support, especially during challenging times for startups. They emphasize radical candor and dedication to the founders they back, aiming to foster transformative growth and industry disruption.